You just read:

Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for 'Off-Label' Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems

News provided by

U.S. Food and Drug Administration

Apr 24, 2020, 10:20 ET